New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 25, 2014
14:23 EDTCVS, WAG, RADWalgreens climbs after reporting same-store sales gain, store closure plans
Shares of drug store owner Walgreens (WAG) are advancing despite the company reporting lower than expected profits as its revenue came in close to expectations and said its Alliance Boots synergies are tracking ahead of expectations. WHAT'S NEW: Walgreens reported earnings per share, excluding some items, of 91c for the second quarter of fiscal 2014, compared with analysts' consensus estimate of 93c. The retailer's Q2 revenue was $19.6B, in-line with the consensus estimate. Walgreens' same-store sales rose 4.3% last quarter. Moreover the company predicted that its fiscal 2016 revenue, including a contribution from Alliance Boots, would be over $130B. Walgreens has a 45% stake in Alliance Boots and has an option to acquire the rest of the European retailer in 2015. "Our second quarter performance, in spite of expected headwinds from slower generic drug introductions, comparisons with last year’s flu season and severe weather, was marked by solid top-line growth driven by record quarterly sales and record second-quarter prescriptions filled,” said Walgreens CEO Greg Wasson in a statement. “We also continued to gain prescription market share while we maintained a firm hold on our costs," Wasson added. Walgreens also announced that as part of its efforts to optimize the company’s asset base, it plans to close 76 drugstores during the second half of this fiscal year. Including these store closures, Walgreens still expects a net increase in its store count in fiscal 2014 of approximately 55-75 locations. PRICE ACTION: In mid-afternoon trading, Walgreens rose $1.75, or 2.72%, to $66.06. Other major U.S. drug store chains also climbed, with Rite Aid (RAD) adding 2.4% and CVS (CVS) gaining 0.6%.
News For WAG;CVS;RAD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 14, 2015
10:34 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
07:58 EDTRADRite Aid has a conference call hosted by JPMorgan
JPMorgan Analyst Gill will host a conference call with CEO John Standley on April 21 at 1 pm.
April 13, 2015
10:33 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
April 9, 2015
14:25 EDTRADRite Aid volatility stays elevated after into Q4 and outlook
Subscribe for More Information
10:32 EDTRADOptions with decreasing implied volatility
Subscribe for More Information
April 8, 2015
16:01 EDTRADActionable Options for Wednesday, April, 8
Subscribe for More Information
09:55 EDTRADRite Aid guidance looks conservative, says JPMorgan
Subscribe for More Information
09:35 EDTRADActive equity options trading on open
Subscribe for More Information
07:13 EDTRADRite Aid up 3.6% after reporting Q4 results
Subscribe for More Information
07:08 EDTRADRite Aid reports Q4 SSS up 4.5%
Same store sales for the quarter increased 4.5% over the prior year, consisting of a 5.7% increase in pharmacy sales and a 2.0% increase in front-end sales. Pharmacy sales included a negative impact of approximately 128 basis points from new generic introductions. The number of prescriptions filled in same stores increased 3.5% over the prior year period. Prescription sales accounted for 68.1% of total drugstore sales, and third party prescription revenue was 97.5% of pharmacy sales.
07:05 EDTRADRite Aid sees FY16 EPS 19c-27c, consensus 43c
Subscribe for More Information
07:03 EDTRADRite Aid reports Q4 EPS ex-items 12c, consensus 7c
Reports Q4 revenue $6.85B, consensus $6.8B. Reports Q4 net income of $1.835B, or $1.79 per diluted share. Current year results for both Q4 and the full year were favorably impacted by a reduction of the deferred tax asset valuation allowance and a full year provision of income tax expense at a statutory tax rate, the net effect of which resulted in an income tax benefit of $1.716B, or $1.67 per diluted share and $1.682B, or $1.65 per diluted share in the fourth quarter and full year, respectively.
April 7, 2015
15:43 EDTRADRite Aid trades at multi-year highs ahead of earnings, levels to watch
Subscribe for More Information
15:30 EDTRADNotable companies reporting before tomorrow's open
Subscribe for More Information
08:37 EDTRADRite Aid volatility increases into Q4 and outlook
Subscribe for More Information
08:35 EDTRADReed's announces Sonoma Sparklers available at Rite Aid locations
Reed's (REED) announced that Reed's Sonoma Sparklers is now available exclusively in Rite Aid (RAD) stores nationwide. All of the nearly 4,600 Rite Aid stores across the U.S. will feature 16oz bottles of delicious, all-natural Sonoma Sparklers in three flavors: Sparkling Organic Raspberry, Sparkling Organic Lemonade and Sparkling Organic Peach.
08:02 EDTRADJPMorgan says Walgreens may be more willing to buy Rite Aid
Subscribe for More Information
06:08 EDTCVSNew York REIT announces 22,00 square foot lease with CVS at 1440 Broadway
New York REIT (NYRT) announced that is has completed a long-term lease totaling approximately 22,000 square feet with CVS/pharmacy (CVS) at 1440 Broadway. The deal marks the first step in NYRT's overall retail repositioning strategy at 1440 Broadway, with remaining value-add opportunities to mark existing below-market tenant rents to market and to re-configure a portion of the basement into valuable, lower-level selling space with double ceiling-heights.
April 6, 2015
07:12 EDTRADRite Aid volatility elevated into Q4 and outlook
Subscribe for More Information
06:58 EDTRADRite Aid reinstated with an Overweight at JPMorgan
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use